Jun 24, 2024
SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application
Jun 13, 2024
SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM(TM) Platform
May 30, 2024
SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care
May 29, 2024
SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities
May 16, 2024
Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICS
Apr 23, 2024
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa
Apr 17, 2024
SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)
Apr 04, 2024
SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership
Feb 07, 2024
SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
Jan 25, 2024
SOPHiA GENETICS Supports Genetic Testing in Brazil
Jan 18, 2024
SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio
Jan 10, 2024
SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference
Jan 08, 2024
Exactis Innovation and SOPHiA GENETICS Announce Collaboration on Multimodal Data Analytics
Feb 11, 2021
SOPHiA GENETICS Appoints Ross Muken as Chief Financial Officer
Feb 08, 2021
SOPHiA GENETICS and the Spanish Lung Cancer Group Team Up to Explore the Predictive Potential of Multimodal Health Data in Resectable Stage IIIA Non-Small Cell Lung Cancer
Jan 19, 2021
SOPHiA GENETICS Appoints Influential Regulatory Figure Kathy L. Hibbs to Board of Directors
Nov 17, 2020
Bram Goorden joins SOPHiA GENETICS as Chief Commercial Officer and Head of North America
Oct 01, 2020
SOPHiA GENETICS Raises $110 Million in Oversubscribed New Funding Round
Apr 08, 2020
SOPHiA GENETICS Expands Its Executive Team, Naming Lara Hashimoto Chief Business Officer
Mar 26, 2020
SOPHiA GENETICS and Paragon Genomics Join Forces Against the COVID-19 Coronavirus Pandemic